Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Poorly Differentiated Prostate Adenocarcinoma

An invasive prostate adenocarcinoma characterized by the presence of malignant cells exhibiting poor differentiation.
National Institutes of Health

Related topics

Related topics

13 relations
ERG geneEpithelial CellsEpitheliumMale Reproductive System
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
18F-FDG PET/CT superscan in prostate cancer.
F-FDG PET/CT of a patient with inflammatory lower back pain reveals diffuse bony metastases, similar to the "superscan" found on… Expand
Is this relevant?
2013
2013
Isolated cerebellar metastasis from prostate adenocarcinoma diagnosed by 18F-fluorocholine PET/CT: a rare but not impossible complication
In living patients brain metastases of prostate cancer are extremely rare (1 %), generally occurring in end-stage disease when… Expand
Is this relevant?
2006
2006
Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from…
An optimal immunohistochemical panel to distinguish poorly differentiated prostate (PCa) from urothelial (UCa) carcinoma was… Expand
Is this relevant?
2005
2005
Orbital metastasis from prostate cancer: an atypical case of neuroendocrine dedifferentiation during progression from hormone-sensitive to refractory stage.
We report a case of orbital metastasis from a neuroendocrine dedifferentiated prostate cancer during progression from hormone… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade.
Id1 and Id3 genes are required for vascularization, growth, and metastasis of xenograft tumors. In Id-deficient mice, tumor… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2002
2002
Immunohistochemical profile of high-grade urothelial bladder carcinoma and prostate adenocarcinoma.
The differential diagnosis between poorly differentiated prostate adenocarcinoma (PAC) involving the bladder and high-grade… Expand
Is this relevant?
2000
2000
WISH-PC2: a unique xenograft model of human prostatic small cell carcinoma.
Prostatic small cell carcinoma is an aggressive subtype of prostate cancer that usually appears as a progression of the original… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
2000
2000
WISH-PC 2 : A Unique Xenograft Model of Human Prostatic Small Cell Carcinoma 1
Prostatic small cell carcinoma is an aggressive subtype of prostate cancer that usually appears as a progression of the original… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Pathologic progression of autochthonous prostate cancer in the TRAMP model
The ability to manipulate gene expression in specific cell types at specific times utilizing transgenic technology has allowed… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1997
1997
Endopeptidase 24.11 activity in the human prostate cancer cell lines LNCaP and PPC-1
Human endopeptidase 24.11 (EP) occurs in greatest abundance on terminally differentiated prostate cells; thus, loss of EP could… Expand
  • figure 1
  • table 1
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE